Literature DB >> 11852185

Elevated levels of phosphorylated neurofilament proteins in cerebrospinal fluid of Alzheimer disease patients.

Yuan-Yuan Hu1, Shan-Shu He, Xiao-Chuang Wang, Qiu-Hong Duan, Sabiha Khatoon, Khalid Iqbal, Inge Grundke-Iqbal, Jian-Zhi Wang.   

Abstract

Neurofilament (NF) subunits NF-H, NF-M and NF-L are hyperphosphorylated and elevated in Alzheimer disease (AD) brain. We investigated the level and phosphorylation states of NF subunits in lumbar cerebrospinal fluid (CSF) from living patients by bienzyme substrate-recycle enzyme-linked immunosorbent assay. We found: (i), that the levels of phosphorylated NF-H/M (pNF-H/M), non-phosphorylated NF-H/M (npNF-H/M) and NF-L were significantly higher (pNF-H/M, approximately 12-24-fold; npNF-H/M, approximately 3-4-fold) in neurologically healthy aged people than young control individuals; (ii), that in AD, the levels of npNF-H/M, and NF-L were similar to vascular dementia (VaD), and higher than in age-matched controls; and (iii), that the levels of pNF-H/M were significantly higher than in aged controls, non-AD neurological disorders and VaD. Based on these findings, it is suggested that the increased level of total NF proteins in CSF could be used as a marker for brain aging and neurodegenerative disorders in general, and the levels of pNF-H/M as a marker to discriminate AD from normal brain aging and as well as neurological conditions including VaD.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11852185     DOI: 10.1016/s0304-3940(02)00047-2

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  31 in total

Review 1.  Some recent advances in basic neuroscience research in China.

Authors:  Mu-ming Poo; Aike Guo
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2007-06-29       Impact factor: 6.237

2.  Inhibition of melatonin biosynthesis induces neurofilament hyperphosphorylation with activation of cyclin-dependent kinase 5.

Authors:  Shaohui Wang; Lingqiang Zhu; Hairong Shi; Hongyun Zheng; Qing Tian; Qun Wang; Rong Liu; Jian-Zhi Wang
Journal:  Neurochem Res       Date:  2007-03-31       Impact factor: 3.996

Review 3.  Cerebrospinal fluid protein biomarkers for Alzheimer's disease.

Authors:  Kaj Blennow
Journal:  NeuroRx       Date:  2004-04

4.  Levels of cerebrospinal fluid neurofilament light protein in healthy elderly vary as a function of TOMM40 variants.

Authors:  Davide Bruno; Nunzio Pomara; Jay Nierenberg; James C Ritchie; Michael W Lutz; Henrik Zetterberg; Kaj Blennow
Journal:  Exp Gerontol       Date:  2011-10-01       Impact factor: 4.032

5.  CSF neurofilament proteins as diagnostic and prognostic biomarkers for amyotrophic lateral sclerosis.

Authors:  Daniela Rossi; Paolo Volanti; Liliana Brambilla; Tiziana Colletti; Rossella Spataro; Vincenzo La Bella
Journal:  J Neurol       Date:  2018-01-10       Impact factor: 4.849

6.  Comparative proteomics analysis of cerebrospinal fluid of patients with Guillain-Barré syndrome.

Authors:  Yin-Rong Yang; Shi-Lian Liu; Zhao-Yu Qin; Fu-Jun Liu; Yan-Jiang Qin; Shu-Mei Bai; Zhe-Yu Chen
Journal:  Cell Mol Neurobiol       Date:  2008-03-15       Impact factor: 5.046

7.  Uncovering molecular biomarkers that correlate cognitive decline with the changes of hippocampus' gene expression profiles in Alzheimer's disease.

Authors:  Martín Gómez Ravetti; Osvaldo A Rosso; Regina Berretta; Pablo Moscato
Journal:  PLoS One       Date:  2010-04-13       Impact factor: 3.240

8.  No neurochemical evidence for brain injury caused by heading in soccer.

Authors:  Henrik Zetterberg; Michael Jonsson; Abdullah Rasulzada; Cornel Popa; Ewa Styrud; Max Albert Hietala; Lars Rosengren; Anders Wallin; Kaj Blennow
Journal:  Br J Sports Med       Date:  2007-05-11       Impact factor: 13.800

Review 9.  Specialized roles of neurofilament proteins in synapses: Relevance to neuropsychiatric disorders.

Authors:  Aidong Yuan; Ralph A Nixon
Journal:  Brain Res Bull       Date:  2016-09-05       Impact factor: 4.077

10.  Effect of melatonin and melatonylvalpromide on beta-amyloid and neurofilaments in N2a cells.

Authors:  Xiao-Chuan Wang; Yin-Chun Zhang; Nithiananda Chatterjie; Inge Grundke-Iqbal; Khalid Iqbal; Jian-Zhi Wang
Journal:  Neurochem Res       Date:  2008-01-31       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.